ECTTA Specialty Update Symposium
SUNDAY 13 SEPTEMBER
09:00 – 12:50 ECTTA Specialty Update Symposium
SESSION 1: Thoracic organ donor management: setting the standards and pushing the limits
CHAIRS: Arne Neyrinck, Leuven, Belgium
Luciano Potena, Bologna, Italy
09.00 Report from the Consensus Conference on Thoracic Organ Donors: recommendations and unmet needs
Arne Neyrinck, Leuven, Belgium
09.20 Debate: How to improve transportation and reconditioning of explanted lungs:
- reconditioning while warm perfusion
Dirk Van Raemdonck, Leuven, Belgium
- cold transportation and then bench reconditioning
Shaf Keshavjee, Toronto, Canada
10.00 How to optimize heart preservation and recovery
Bruno Podesser, Vienna
10.20 Resuscitating and transplanting a non-beating heart: “it-could-work!”
Peter Macdonald, Sydney, Australia
10.40 Featured abstract: "Europe's First Successful DCD Heart Transplant With Functional Assessment"
Simon Messer, London, United Kingdom
10:55 – 11:15 Coffee Break
SESSION 2: Controversy and new knowledge in the management of machines and immunity
CHAIRS: Michiel Erasmus, Groningen, The Netherlands
Ugo Livi, Udine, Italy
11.15 Debate: Optimize transplantation timing in VAD patients on the waiting list:
- Only stable VAD patients should be transplanted
Andreas Zuckermann, Vienna, Austria
- Only complicated VAD patients should be transplanted
Evgenij Potapov, Berlin, Germany
11.45 Modalities, indications and outcomes of patients needing ECMO support before lung Transplantation
Franco Valenza, Milan, Italy
12.05 Mechanisms of antibody mediated injury: looking for therapeutic targets in thoracic transplantation
Elaine Reed, Los Angeles, United States
12.25 Featured abstract: "Lung Transplantation Outcome Is Mainly Driven By Antibody Mediated Rejection"
Antoine Roux, Paris, France
12.40 Closing remarks
ECCTA in pills:
ECTTA has been endorsed to promote initiatives aimed at improving the educational and scientific opportunities ESOT can offer to professionals involved in heart and lung transplantation.
Our ambition is to become a gathering home to foster scientific growth, exchange programs, collaborative projects and funding opportunities dedicated to European heart and lung transplantation programs;
Improve quality of care for patients with end-stage heart or lung disease and for thoracic organ transplant recipients. Advance education and stimulate networking amongst thoracic transplant professionals.
To provide updates on the etiologies, mechanisms, treatment strategies and diagnostic tools of early and late dysfunction of the transplanted heart and lungs. The lectures will focus on the main strategies and mechanisms leading to graft dysfunction starting from donor and organ management, to prevention of long-term chronic immunological injury leading to graft impairment.
Cardiologists, Pneumologists, Cardio-thoracic surgeons, Anestesiologists, Transplant coordinators.